Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
R Mohanka, M Menegus, C Ryan… - Transplantation …, 2005 - Elsevier
INTRODUCTION: Cytomegalovirus (CMV) infection after solid organ transplantation is one
of the most common viral infections, causing significant morbidity and mortality if not treated …
of the most common viral infections, causing significant morbidity and mortality if not treated …
Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
A Jain, M Orloff, R Kashyap, K Lansing… - Transplantation …, 2005 - europepmc.org
Results Twenty-nine patients (14.3%) developed symptomatic CMV disease at 169+/-117
days after liver transplantation: group 1, 16.4% versus group 2, 7.3% versus group 3, 25.9 …
days after liver transplantation: group 1, 16.4% versus group 2, 7.3% versus group 3, 25.9 …
[PDF][PDF] Does Valganciclovir Hydrochloride (Valcyte) Provide Effective Prophylaxis Against Cytomegalovirus Infection in Liver Transplant Recipients?
A Jain, M Orloff, R Kashyap, K Lansing… - Transplantation …, 2005 - drashokjain.com
Introduction. Cytomegalovirus (CMV) infection after solid organ transplantation is one of the
most common viral infections, causing significant morbidity and mortality if not treated …
most common viral infections, causing significant morbidity and mortality if not treated …
Does Valganciclovir Hydrochloride (Valcyte) Provide Effective Prophylaxis Against Cytomegalovirus Infection in Liver Transplant Recipients?
A Jain, M Orloff, R Kashyap, K Lansing, R Betts… - Transplantation …, 2005 - infona.pl
Cytomegalovirus (CMV) infection after solid organ transplantation is one of the most
common viral infections, causing significant morbidity and mortality if not treated promptly …
common viral infections, causing significant morbidity and mortality if not treated promptly …
[PDF][PDF] Does Valganciclovir Hydrochloride (Valcyte) Provide Effective Prophylaxis Against Cytomegalovirus Infection in Liver Transplant Recipients?
A Jain, M Orloff, R Kashyap, K Lansing… - Transplantation …, 2005 - academia.edu
Introduction. Cytomegalovirus (CMV) infection after solid organ transplantation is one of the
most common viral infections, causing significant morbidity and mortality if not treated …
most common viral infections, causing significant morbidity and mortality if not treated …
Does valganciclovir hydrochloride (Valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
A Jain, M Orloff, R Kashyap, K Lansing, R Betts… - 2005 - cabidigitallibrary.org
Introduction: Cytomegalovirus (CMV) infection after solid organ transplantation is one of the
most common viral infections, causing significant morbidity and mortality if not treated …
most common viral infections, causing significant morbidity and mortality if not treated …
Does valganciclovir hydrochloride (Valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
A Jain, M Orloff, R Kashyap, K Lansing… - Transplantation …, 2005 - pure.psu.edu
Introduction. Cytomegalovirus (CMV) infection after solid organ transplantation is one of the
most common viral infections, causing significant morbidity and mortality if not treated …
most common viral infections, causing significant morbidity and mortality if not treated …
[引用][C] Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
A JAIN, M ORLOFF, R KASHYAP… - Transplantation …, 2005 - pascal-francis.inist.fr
Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against
cytomegalovirus infection in liver transplant recipients? CNRS Inist Pascal-Francis CNRS …
cytomegalovirus infection in liver transplant recipients? CNRS Inist Pascal-Francis CNRS …
Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
A Jain, M Orloff, R Kashyap… - Transplantation …, 2005 - pubmed.ncbi.nlm.nih.gov
Introduction Cytomegalovirus (CMV) infection after solid organ transplantation is one of the
most common viral infections, causing significant morbidity and mortality if not treated …
most common viral infections, causing significant morbidity and mortality if not treated …
[PDF][PDF] Does Valganciclovir Hydrochloride (Valcyte) Provide Effective Prophylaxis Against Cytomegalovirus Infection in Liver Transplant Recipients?
A Jain, M Orloff, R Kashyap, K Lansing… - Transplantation …, 2005 - drashokjain.com
Introduction. Cytomegalovirus (CMV) infection after solid organ transplantation is one of the
most common viral infections, causing significant morbidity and mortality if not treated …
most common viral infections, causing significant morbidity and mortality if not treated …